Crossmark

Development and cross-national investigation of a model explaining participation in WHO-recommended and placebo behaviours to prevent COVID-19 infection

Crossref DOI link: https://doi.org/10.1038/s41598-022-17303-y

Published Online: 2022-10-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kłosowska, Joanna https://orcid.org/0000-0002-2583-6870
Bajcar, Elżbieta A.

Bieniek, Helena

Brączyk, Justyna

Joshanloo, Mohsen

Mattarozzi, Katia

Bagnis, Arianna

Pontén, Moa

Lalouni, Maria

Geers, Andrew L.

Clemens, Kelly S.

Park, Joonha

Choi, Gahee

Choi, Yun-Kyeung

Jung, Wookyoung

Son, Eunjung

Yoon, Hyae Young

Bąbel, Przemysław
Funding

Funding for this research was provided by:

Narodowe Centrum Nauki (2016/23/B/HS6/03890)
License Information

Text and Data Mining valid from 2022-10-21

Version of Record valid from 2022-10-21
More Information

Article History

Received: 19 March 2022

Accepted: 22 July 2022

First Online: 21 October 2022

Change Date: 21 February 2026

Change Type: Update

Change Details: The original online version of this Article was revised: In the original version of this Article the Funding section was omitted. The Funding section now reads: “Article Processing Charges were funded by a grant from the Strategic Program Excellence Initiative at the Jagiellonian University (Faculty of Philosophy).”

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below